| KOTAŠKOVÁ, Jana, Andrea MAREČKOVÁ, Daniela POKRIVČÁKOVÁ, Eva ONDROUŠKOVÁ, Anna FIDRICHOVÁ, Lenka BRYJOVÁ, Viera HRABČÁKOVÁ, Jakub Paweł PORC, Veronika NAVRKALOVÁ, Karla PLEVOVÁ, Marie JAROŠOVÁ, Šárka POSPÍŠILOVÁ, Martin ŠTORK and Luděk POUR. Identification of genetic aberrations in multiple myeloma patients with low tumour burden using comprehensive NGS testing. In EHA-SWG Scientific Meeting Integrated Cell Tracking in Oncohematology: Diagnosis, Targeted Therapy and Residual Disease, Francie, Bordeaux. 2022. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{2238281,
author = {Kotašková, Jana and Marečková, Andrea and Pokrivčáková, Daniela and Ondroušková, Eva and Fidrichová, Anna and Bryjová, Lenka and Hrabčáková, Viera and Porc, Jakub Paweł and Navrkalová, Veronika and Plevová, Karla and Jarošová, Marie and Pospíšilová, Šárka and Štork, Martin and Pour, Luděk},
booktitle = {EHA-SWG Scientific Meeting Integrated Cell Tracking in Oncohematology: Diagnosis, Targeted Therapy and Residual Disease, Francie, Bordeaux},
title = {Identification of genetic aberrations in multiple myeloma patients with low tumour burden using comprehensive NGS testing.},
year = {2022}
}
TY - CONF
ID - 2238281
AU - Kotašková, Jana - Marečková, Andrea - Pokrivčáková, Daniela - Ondroušková, Eva - Fidrichová, Anna - Bryjová, Lenka - Hrabčáková, Viera - Porc, Jakub Paweł - Navrkalová, Veronika - Plevová, Karla - Jarošová, Marie - Pospíšilová, Šárka - Štork, Martin - Pour, Luděk
PY - 2022
TI - Identification of genetic aberrations in multiple myeloma patients with low tumour burden using comprehensive NGS testing.
ER -
KOTAŠKOVÁ, Jana, Andrea MAREČKOVÁ, Daniela POKRIVČÁKOVÁ, Eva ONDROUŠKOVÁ, Anna FIDRICHOVÁ, Lenka BRYJOVÁ, Viera HRABČÁKOVÁ, Jakub Paweł PORC, Veronika NAVRKALOVÁ, Karla PLEVOVÁ, Marie JAROŠOVÁ, Šárka POSPÍŠILOVÁ, Martin ŠTORK and Luděk POUR. Identification of genetic aberrations in multiple myeloma patients with low tumour burden using comprehensive NGS testing. In \textit{EHA-SWG Scientific Meeting Integrated Cell Tracking in Oncohematology: Diagnosis, Targeted Therapy and Residual Disease, Francie, Bordeaux}. 2022.
|
